Prediction of COPD by the single-breath nitrogen test and various respiratory symptomsShow others and affiliations
2021 (English)In: ERJ Open Research, E-ISSN 2312-0541, Vol. 7, no 3, article id 00383-2021Article in journal (Refereed) Published
Abstract [en]
Early identification of subjects running an increased risk of contracting COPD enables focus on individual preventive measures. The slope of the alveolar plateau of the single-breath nitrogen washout test (N-2-slope) is a sensitive measure of small-airway dysfunction. However, its role remains unexplored in predicting hospital admission or death related to COPD, i.e. incident COPD events, in relation to the presence of various respiratory symptoms. A random population sample of 625 men, aged 50 (n=218) or 60 years (n=407), was followed for 38 years for incident COPD events. At baseline, a questionnaire on respiratory symptoms and smoking habits was collected, spirometry and the single-breath nitrogen test were performed, and the N-2-slope was determined. Proportional hazard regression (Cox regression) analysis was used for the prediction model. The N-2-slope improved the prediction of COPD events significantly beyond that of respiratory symptoms weighted all together and other covariates (hazard ratio 1.63, 95% CI 1.20-2.22; p<0.005), a prediction applicable to subjects without (p=0.001) and with (p<0.05) airway obstruction. Dyspnoea and wheezing were the most predictive symptoms. The combination of the N-2-slope and number of respiratory symptoms notably resulted in an effective prediction of incident COPD events even in nonobstructive subjects, as evidenced by a predicted incidence of similar to 70% and similar to 90% for a very steep N-2-slope combined with many respiratory symptoms in subject without and with airway obstruction, respectively. The alveolar N-2-slope should be considered in the critical need for further research on early diagnosis of COPD.
Place, publisher, year, edition, pages
European Respiratory Society (ERS) European Respiratory Society, 2021. Vol. 7, no 3, article id 00383-2021
National Category
Respiratory Medicine and Allergy
Identifiers
URN: urn:nbn:se:uu:diva-458263DOI: 10.1183/23120541.00383-2021ISI: 000707130700008PubMedID: 34589539OAI: oai:DiVA.org:uu-458263DiVA, id: diva2:1609541
Funder
Swedish Heart Lung Foundation2021-11-082021-11-082024-01-15Bibliographically approved